Amphetamine psychosis: behavioral and biochemical aspects.
D000293:Adolescent; D000328:Adult; D000339:Affect; D000437:Alcoholism / Q000134:cerebrospinal fluid; D000661:Amphetamine / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D001921:Brain / Q000378:metabolism*; D003072:Cognition Disorders / Q000139:chemically induced; D003702:Delusions / Q000139:chemically induced; D003863:Depression / Q000139:chemically induced; D003913:Dextroamphetamine / Q000494:pharmacology; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004298:Dopamine / Q000378:metabolism*; D004305:Dose-Response Relationship, Drug; D005026:Ethylene Glycols / Q000134:cerebrospinal fluid; D006212:Hallucinations / Q000139:chemically induced; D006220:Haloperidol / Q000627:therapeutic use; D006719:Homovanillic Acid / Q000134:cerebrospinal fluid; D006801:Humans; D008297:Male; D008734:Methoxyhydroxyphenylglycol / Q000134:cerebrospinal fluid; D011605:Psychoses, Substance-Induced / Q000188:drug therapy / Q000378:metabolism*; D011955:Receptors, Drug; D012559:Schizophrenia / Q000134:cerebrospinal fluid / Q000378:metabolism*; D012564:Schizophrenic Language; D012565:Schizophrenic Psychology; D013237:Stereoisomerism
D005026:Ethylene Glycols; D011955:Receptors, Drug; D008734:Methoxyhydroxyphenylglycol; D004295:Dihydroxyphenylalanine; D000661:Amphetamine; D006220:Haloperidol; D003913:Dextroamphetamine; D004298:Dopamine; D006719:Homovanillic Acid